help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Citters, G. W.
Right arrow Articles by Bergman, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Citters, G. W.
Right arrow Articles by Bergman, R. N.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 11 5191-5198
Copyright © 2002 by The Endocrine Society


Original Article

Elevated Glucagon-Like Peptide-1-(7–36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding

Gregg W. Van Citters, Morvarid Kabir, Stella P. Kim, Steven D. Mittelman, Melvin K. Dea, Patricia L. Brubaker and Richard N. Bergman

Department of Physiology and Biophysics (G.W.V.C., M.K., S.P.K., S.D.M., M.K.D., R.N.B.), Keck School of Medicine, University of Southern California, Los Angeles, California 90089-9142; and Department of Physiology (P.L.B.), University of Toronto, Toronto, Ontario, M5S 1A8 Canada

Address all correspondence and requests for reprints to: Richard N. Bergman, Ph.D., Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, 1333 San Pablo Street, MMR 626, Los Angeles, California 90089-9142. E-mail: rbergman{at}usc.edu.

Abstract

We previously developed a canine model of central obesity and insulin resistance by supplementing the normal chow diet with 2 g cooked bacon grease/kg body weight. Dogs fed this fatty diet maintained glucose tolerance with compensatory hyperinsulinemia. The signal(s) responsible for this up-regulation of plasma insulin is unknown. We hypothesized that meal-derived factors such as glucose, fatty acids, or incretin hormones may signal ß-cell compensation in the fat-fed dog. We fed the same fat-supplemented diet for 12 wk to six dogs and compared metabolic responses with seven control dogs fed a normal diet. Fasting and stimulated fatty acid and glucose-dependent insulinotropic peptide concentrations were not increased by fat feeding, whereas glucose was paradoxically decreased, ruling out those three factors as signals for compensatory hyperinsulinemia. Fasting plasma glucagon-like peptide-1 (GLP-1) concentration was 2.5-fold higher in the fat-fed animals, compared with controls, and 3.4-fold higher after a mixed meal. Additionally, expression of the GLP-1 receptor in whole pancreas was increased 2.3-fold in the fat-fed dogs. The increase in both circulating GLP-1 and its target receptor may have increased ß-cell responsiveness to lower glucose. Glucose is not the primary cause of hyperinsulinemia in the fat-fed dog. Corequisite meal-related signals may be permissive for development of hyperinsulinemia.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. E. Bates, A. Sirek, M. A. Kiraly, J. T. Y. Yue, M. C. Riddell, S. G. Matthews, and M. Vranic
Adaptation to intermittent stress promotes maintenance of {beta}-cell compensation: comparison with food restriction
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E947 - E958.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. J Little, M. Horowitz, and C. Feinle-Bisset
Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 531 - 541.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Kabir, K. J. Catalano, S. Ananthnarayan, S. P. Kim, G. W. Van Citters, M. K. Dea, and R. N. Bergman
Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E454 - E461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. D'Alessio and T. P. Vahl
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society